Important resource!

Glycoimmunology is starting to get some much-deserved attention! Octagon Therapeutics has made some fundamental discoveries into how these humble sugar moieties drive #autoimmune disease and #inflammation endpts.com/palleon-unveil…

Glycosylation is fundamental to immune functioning (and pathology!), but the tools needed to study these humble carbohydrates are only now becoming available. lnkd.in/eRNneHJu

Another really interesting example of the crucial role glycosylation has in immune development, activation, and response. Glycoimmunology is eating the world pubmed.ncbi.nlm.nih.gov/37344746/

We're thrilled to be adding Dr. Michael Elliott to the roster as we begin to move from discovery into development! His translational skills and experience are truly impressive.

Glycoimmunology! Not just good for oncology... Octagon Therapeutics has made some fundamental discoveries around how this biology can drive autoimmune disease

Glycans are fundamental to immunology and contain a tremendous amount of information! news.mit.edu/2023/explained…

Wishing you a relaxing holiday season full of happiness and cheer and well-run lymphocyte analyses!

Thinking hard about glycoimmunology at our weekly data review. Incredibly fun to be working with this many smart people on an important problem!

We are excited to welcome new and existing investors into this equity financing round led by Slater Technology Fund. Octagon is developing important immunomodulatory medicines for patients with chronic autoimmune and inflammatory diseases. Onwards! pitchbook.com/profiles/compa…

Are you looking for your next role at a fast-growing immunology company? Do you love science and care deeply about building better medicines for patients with #autoimmunedisease? Octagon Therapeutics is hiring: - Lab Manager - Research Scientist I - other [email protected]

We could not be more excited to announce this important milestone. Building a recognizable brand is often overlooked by fast-growing biotech companies. This is a big step forward for Octagon Therapeutics

Octagon's updated website is live. Nice to be able to tell the world a little more about what we are doing. And no, we did not sign on aging former pro-wrestlers to our Business Advisory Board! Octagon Therapeutics #autoimmunedisease #inflammation octagontherapeutics.com

Listen to Octagon Therapeutics co-founder Isaac Stoner discussing what it takes to build a biotech, current trends in the industry, and all sorts of other stuff! recruitomics.com/podcast/episod…

I'm very excited about Octagon's expanded Board of Directors. These veteran leaders are going to help power our novel immunomodulatory medicines into the clinic. octagontherapeutics.com/about

Treatment approaches that deplete or suppress healthy immune cells put patients at risk. Octagon Therapeutics is developing immunomodulatory therapies that reset immune homeostasis while sparing protective immunity! endpts.com/infections-are…

We're excited to announce the addition of Liguo (Vicky) Wu to our core team! Dr. Wu brings a wealth of expertise in translational immunology and will play an important role in leading our R&D efforts. #glycoimmunology #autoimmune #inflammation

Tune in tomorrow for a new episode of Biorasi's Few & Far Between podcast. Host Chris O'Brien welcomes Isaac Stoner, CEO at Octagon Therapeutics, to the podcast to zoom in on #autoimmune disease, the role of the CEO, and effective funding strategies. #YourGoToCRO #clinicaltrials #CROs

Learn about Octagon Therapeutics approach to immune pathology and listen to CEO Isaac Stoner talkin about his journey in biotech! …bout-rare-disease-research.castos.com/episodes/episo…

Octagon is hiring! See job posting below linkedin.com/posts/octagont…